Approval · Notice of Compliance 10803 · 2009
TRELSTAR: Notice of Compliance 10803
Issued November 25, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10803
- Date
- November 25, 2009
- Company
- Watson Laboratories IncMarkham, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product name change
- Therapeutic class
- Luteinizing hormone-releasing hormone (LHRH) analog
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TRELSTAR | 02243856 | Marketed |
Medicinal ingredients
- TRIPTORELIN PAMOATE 11.25 MG per VIAL